METOXIA is a five year research project and also defined as a large-scale integrating project.

The project has received funding from the European Union’s Seventh Framework Programme for research, technological development and demonstration under grant agreement no 222741. METOXIA started 1.2.2009. Call identifier is FP7-HEALTH-2007-B.

The scientific background is based on the  concept that hypoxic micro-environments in solid cancer tumors are the major drivers of metastatic spread of cancer.  At the same time such micro-environments reduces the effect of radiotherapy as well as some types of chemotherapy.

The METOXIA project aims at increasing the knowledge concerning the metastatic process in the hypoxic micro-environment at the molecular level in order to develop novel strategies for improved biomarkers for diagnosis as well as improved chemo- and radiotherapy.


  • No. of partners: 21
  • No. of countries: 11
  • Total budget (€): 15 856 219
  • Total max EC Grant (€): 11 998 300
  • Starting date: 1.2.2009
  • Duration 66 months, until 31.7.2014
Publisert 6. mai 2010 14:53 - Sist endret 28. okt. 2014 11:14